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Hypoxia and interleukin-1b stimulate vascular endothelial
growth factor production in human proximal tubular cells
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Hypoxia and interleukin-1b stimulate vascular endothelial such as RANTES (regulated upon activation, normal
growth factor production in human proximal tubular cells. T-cell expressed and secreted), interleukin-8 (IL-8), and
Background. Vascular endothelial growth factor (VEGF) pro- monocyte chemoattractant protein-1, on stimulation withmotes angiogenesis and inflammatory reactions. VEGF mRNA
proinflammatory cytokines or to bacterial toxins [1–3].is detectable in the proximal tubules of inflamed kidneys but
not in normals. In other organs VEGF gene expression is in- In situ hybridization and immunohistochemical stud-
duced by hypoxia and cytokines such as interleukin 1 (IL-1). ies indicate that tubular cells may also express the gene
To identify the cellular mechanisms in control of tubular VEGF for vascular endothelial growth factor (VEGF) in casesproduction, we studied effects of hypoxia and IL-1b in VEGF
of preglomerular or glomerular vascular inflammatorymRNA levels, VEGF secretion, and activity of the hypoxia-
inducible dimeric transcription factor 1 (HIF-1a/b) in human disease [4]. VEGF is a pluripotent cytokine. In addition
proximal tubular epithelial cells (PTECs) in primary culture. to its mitogenicity for endothelial cells, VEGF stimulates
Methods. PTECs were grown in monolayers from human nitric oxide-dependent dilation of blood vessels, increaseskidneys. Hypoxia was induced by incubation at 3% O2. VEGF the permeability of capillaries, and induces the expres-mRNA was quantitated by competitive polymerase chain reac-
sion of urokinase-type and tissue-type plasminogen acti-tion following reverse transcription. VEGF was measured by
enzyme-linked immunoassay. HIF-1a was demonstrated by vators, as well as of the interstitial metalloproteinase
Western blot analysis and HIF-1 DNA binding by gel shift assay. collagenase, and it is a chemoattractant for leukocytes [5].
Results. Significant amounts of VEGF mRNA and VEGF
The mechanisms in control of the alleged formationprotein were measured in PTEC extracts and culture media,
of VEGF by tubular cells have not been elucidated. Inrespectively. Stimulation of VEGF synthesis at low O2 tension
and following IL-1b treatment was detectable at the protein other tissues, VEGF production can be stimulated by
level only. Nuclear HIF-1a protein levels and HIF-1 binding hypoxic stress, distinct cytokines, and tumor-promoting
to DNA were also increased under these conditions.
phorbol esters [5]. Hypoxia induces transcription of theConclusions. PTECs in culture produce VEGF. One mecha-
VEGF gene and stabilization of VEGF mRNA [6, 7].nism of induction appears to be increased DNA binding of
HIF-1 to hypoxia-responsive elements in the VEGF gene pro- There is a 28 bp hypoxia response element (HRE) lo-
moter. In inflammatory diseases of the kidney, tubular cell- cated approximately 1 kb upstream of the transcription
derived VEGF may contribute to microvascular leakage and
initiation site of the human VEGF gene [8]. Transcrip-monocyte extravasation.
tional activation is mediated by binding of the trans-
acting dimeric protein hypoxia-inducible factor-1 (HIF-
1a/b) to this element [9]. The HIF-1a subunit is theRecent evidence suggests that renal tubules are not
pO2-sensitive partner [10], as it is unstable in normoxiaonly targets, but are also active participants in immune
because of a pO2-dependent degradation domain thatreactions. Tubular cell-derived cytokines are thought to
targets it for ubiquitination [11]. A recent study fromaugment inflammatory processes in the kidney. Human
our laboratory has shown that IL-1b and TNF-a increaseproximal tubular cells in culture have been shown to pro-
HIF-1 DNA binding in normoxic and hypoxic humanduce tumor necrosis factor-a (TNF-a), and chemokines,
hepatoma cells in culture [12]. Previously, IL-1 and TNF-a
have been reported to stimulate VEGF production in aKey words: renal tubules, inflammation, cytokines, microvascular leak-
age, tumor necrosis factor-a. tissue-specific way [5].
The aims of the present study were to investigate: (1)
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process, and (3) the accompanying changes in the level and Hepa1C4 cells were maintained in a-minimal essen-
tial medium (GIBCO BRL Life Technologies, Eggen-of HIF-1a protein and HIF-1 DNA binding activity.
stein, Germany) supplemented with 10% FCS (Sigma).
METHODS Assay of VEGF
Tubular cell cultures The concentration of VEGF in the culture media was
measured by commercial enzyme-linked immunoassayHuman proximal tubular epithelial cell lines (PTECs)
(ELISA; Quantikine; R&D Systems, Wiesbaden, Ger-were cultured according to the method of Detrisac et al
many). The immobilized antibody was monoclonal, while[13] as described previously [14]. In brief, portions of
the second horseradish peroxidase-coupled antibody wasrenal cortex not involved by disease were obtained from
polyclonal. In a previous study, we determined the intra-kidneys removed by surgery for renal cell carcinoma.
assay and interassay coefficients of variance to be 5 andPrimary PTEC cultures were grown on a matrix of fetal
7.5%, respectively, and the lower detection limit to becalf serum (FCS; Biochrom KG Seromed, Berlin, Ger-
9 pg/mL [17]. Secreted VEGF was related to the amountmany). PTECs for maintenance and experiments were
of total cellular protein, which was measured in lysatescultured in serum-free Dulbecco’s modified Eagle’s me-
of washed cultures by means of a protein microdetermi-dium (DMEM)/HAM’s F-12 medium in a 1:1 ratio (Bio-
nation kit based on the biuret/phenol reagent methodchrom KG Seromed). The medium was supplemented
(Sigma).with insulin (5 mg/mL), transferrin (5 mg/mL), selenium
(5 ng/mL), hydrocortisone (36 ng/mL), triiodothyronine RNA extraction and VEGF mRNA quantitation
(4 pg/mL), and epidermal growth factor (10 ng/mL; all
Vascular endothelial growth factor mRNA was quan-from Sigma, Deisenhofen, Germany). PTECs were char-
titated by competitive polymerase chain reaction follow-acterized by binding of monoclonal antibodies directed
ing reverse transcription (RT-PCR). Total RNA wasagainst the epithelial membrane antigen and adenosine
isolated from washed cultures by the acid guanidiniumdeaminase binding proteins [15] and by electron micros-
thiocyanate-phenol-chloroform extraction method [18].copy [16]. Passages 2 through 4 were used for study.
One microgram of total RNA was reverse transcribedSite-directed VEGF production was studied in con-
into first-strand cDNA with oligo-dT15 primer (M-MLVfluent PTEC layers on polycarbonate inserts [16] for
reverse transcriptase; GIBCO). Qualitative RT-PCRsseparate collection of basolateral and apical medium fol-
were carried out for GAPDH and b-actin mRNAs to
lowing 4- or 24-hour incubation periods. The effects of test for the integrity of cDNA. RT-PCR was performed
hypoxia on VEGF mRNA levels and VEGF production in 1 3 reaction buffer (supplied by the manufacturer)
were studied in nonconfluent cultures in tissue flasks with 1.5 mmol/L MgCl2, 200 mmol/L of each dNTP, 0.4(25 cm2 with 5 mL medium) placed in a pO2-controlled mmol/L of each 59 and 39 primer, 1 mL of cDNA template,
incubator (Heraeus, Hanau, Germany) with 20% O2 or and 0.75 U of Taq DNA polymerase (GIBCO) in a total
3% O2, 5% CO2, and balance N2 in a humidified atmo- reaction volume of 50 mL. The primer sequences and
sphere at 378C for different periods of up to three days. PCR conditions are listed in Table 1. The PCR products
To study the effects of proinflammatory cytokines on were analyzed by agarose gel electrophoresis. The com-
VEGF production, the cells were subcultured in 24-well petitive PCR contained 10 mL of competitor DNA for
dishes (2 cm2 with 1 mL medium). Cytokines used were the VEGF165 isoform and 10 mL of cDNA. The VEGF
recombinant human IL-1b (provided by Ciba-Geigy, Ba- competitor was constructed as described recently [19].
sel, Switzerland), TNF-a (6.6 3 106 U/mg by L 929 bio- For each cDNA sample, we performed a set of four to
assay; provided by BASF/Knoll, Ludwigshafen, Ger- six reactions with different amounts of competitor. Its
many), and IL-6 (Sigma). IL-1b was also tested for its concentration ranged from 2.5 to 0.08 pg/mL in 1:2 dilu-
effect on VEGF mRNA levels. Phorbol 12-myristate 13- tions. PCR products generated from the cDNA and the
acetate (PMA; Sigma) was used as a positive control competitor template were distinguishable by size (341
agent for stimulation of VEGF production. vs. 269 bp) when run on an 3% (wt/vol) agarose gel
stained with ethidium bromide. VEGF mRNA concen-
Murine hepatoma cultures trations per mg of total RNA were calculated after deter-
Since the existence of HIF-1 and its capacity to bind mination of the equilibrium between PCR products from
to DNA has not been demonstrated thus far in tubular cDNA and competitor DNA, as described by Fandrey
cells, control experiments were carried out with the mu- and Bunn [20].
rine hepatoma cell lines Hepa1 and Hepa1C4 (kindly
Nuclear extract preparation for study ofprovided by Dr. O. Hankinson, Los Angeles, CA, USA).
HIF-1 activationHepa1 cells exhibit HIF-1 DNA-binding activity on hyp-
oxia exposure [12], while Hepa1C4 is a Hepa1 subline Hypoxia-inducible factor-1a protein levels and HIF-1
DNA binding were determined in nuclear extracts ofthat does not express a functional HIF-1b subunit. Hepa1
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Table 1. Characterization of polymerase chain reaction (PCR) primers
Position
Primer Sequence (Gene Bank Accession no.) PCR product TAnn Cycles
59-GAPDH 59-ATC ATC CCT GCC TCT ACT GG-39 4296-4315 (J04038) 257 bp 558C 273
39-GAPDH 59-TGG GTG TCG CTG TTG AAG TC-39 4533-4552 (J04038) 257 bp 558C 273
59-b-actin 59-GAA GAG CTA CGA GCT GCC-39 2376-2393 (M10277) 362 bp 588C 253
39-b-actin 59-TGA TCC ACA TCT GCT GGA-39 2927-2944 (M10277) 362 bp 588C 253
59-VEGF 59-GAG GAG GGC AGA ATC ATC AC-39 796-815 (AF022375) 341 bp 588C 323
39-VEGF 59-AGG CCC ACA GGG ATT TTC TTG TC-39 1115-1136 (AF022375) 341 bp 588C 323
TAnn is the annealing temperature.
PTECs incubated with or without IL-1b (300 pg/mL) in blot analysis as described [12]. Samples were run on
sodium dodecyl sulfate/7.5% polyacrylamide gels anda normoxic (20% O2) or hypoxic (3% O2) atmosphere.
For these short-term experiments, PTECs were cultured transferred electrophoretically (Trans-Blot SD; BioRad,
Mu¨nchen, Germany) to nitrocellulose membranes (Am-in conventional Petri dishes of 55 mm diameter or in
special dishes with a gas-permeable fluoroethylene-pro- ersham, Braunschweig, Germany). Equal loading and
transfer efficiency were verified by staining with 2% Pon-pylene copolymer Teflon membrane as the bottom sup-
port (25 mm thickness; Petri-PERMt; Heraeus), which ceau S. Membranes were blocked overnight with PBS/5%
fat-free skim milk and then incubated for two hours atallows one to rapidly adjust the pericellular pO2 to the
pO2 in the gas atmosphere [21]. Hepa1 and Hepa1C4 room temperature with a 1:500 diluted monoclonal mouse
antibody against human HIF-1a (Transduction Labora-cells were grown in conventional Petri dishes of 100 mm
diameter. Nuclear extracts were prepared according to tories, Heidelberg, Germany). For detection, a horserad-
ish peroxidase-linked antimouse IgG antibody (1:2000,Semenza and Wang with minor modifications [22]. Cells
were washed with ice-cold phosphate-buffered saline 1 h at room temperature; Santa Cruz, Heidelberg, Ger-
many) and enhanced chemiluminescence substrate (Am-(PBS), harvested in 6 mL PBS and centrifuged at 400 3 g
for five minutes at 48C. The cell pellets were washed ersham) were used.
with 2 mL ice-cold buffer A (10 mmol/L Tris, pH 7.8,
Gel shift assay of HIF-1 DNA binding1.5 mmol/L MgCl2, 10 mmol/L KCl), resuspended in
1 mL buffer A, and left on ice for 10 minutes. Subse- [g–32P] adenosine 59-triphosphate (ATP) was obtained
quently, cells were lyzed by Dounce homogenization. from New England Nuclear (Ko¨ln, Germany). Oligonu-
Lysis was controlled with trypan blue. Nuclei were pel- cleotides for gel shift assays were synthesized by MWG
leted at 3500 3 g for five minutes at 48C and resuspended (Ebersberg, Germany). The sequences containing the
in 150 mL ice-cold buffer C (420 mmol/L KCl, 20 mmol/L HIF-1 binding sites were derived from the human trans-
Tris, pH 7.8, 1.5 mmol/L MgCl2, 20% glycerol) and incu- ferrin gene (TfHBSww). Rolfs et al established this ex-
bated for 30 minutes on ice with occasional flicking of perimental model, which is well suited for study of HIF-1
the tubes. Just before use, buffers A and C were supple- DNA binding, because two HIF-1 binding sites are pres-
mented with 2 mg/mL aprotinin, 10 mg/mL leupeptin, 20 ent in the TfHBSww enhancer [23].
mg/mL pepstatin, 1 mmol/L Na3VO4, 0.5 mmol/L ben- Sequences were TfHBSww (sense), 59-TTCCTGCACG
zamidine, 2 mmol/L levamisole, 10 mmol/L b-glycero- TACACACAAAGCGCACGTATTTC-39, and TfHBSww
phosphate, 0.5 mmol/L dithiothreitol (DTT) and 0.4 (antisense), 59-GAAATACGTGCGCTTTGTGTGTAC
mmol/L phenylmethylsulfonyl fluoride (PMSF). Nuclei GTGCAGGAA-39.
were centrifuged at 12,000 3 g for 30 minutes at 48C. After 59 end labeling of the sense strand unincorpo-
The supernatant was dialyzed against 1 L of buffer D rated [g-32P], ATP was removed with a Sephadex G50
[100 mmol/L KCl, 20 mmol/L Tris, pH 7.8, 2 mmol/L (Pharmacia, Uppsala, Sweden) column. The annealing
ethylenediaminetetraacetic acid (EDTA), 20% glycerol] reaction was performed in the presence of a twofold
overnight at 48C. After dialysis, nuclear extracts were molar excess of unlabeled antisense oligonucleotides and
collected by a short centrifugation at 48C. Aliquots were a final MgCl2 concentration of 1 mmol/L.
frozen in liquid nitrogen and stored at 2808C. Protein Binding reactions were set up in a volume of 30 mL.
concentrations were determined by the Bradford method Nuclear extracts (3 mg of protein from PTEC or 5 mg of
using bovine serum albumin as standard. protein from murine hepatoma cells) were preincubated
on ice for 30 minutes in a buffer with final concentrations
Western blot analysis of 50 mmol/L KCl, 10 mmol/L Tris, pH 7.7, 5 mmol/L
DTT, 1 mmol/L EDTA, 1 mmol/L MgCl2, 5% glycerol,For determination of immunoreactive HIF-1a protein,
cellular or nuclear extracts were subjected to Western 0.03% NP40, and 600 ng salmon testes DNA. After the
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Table 2. Basolateral versus apical production of vascular
endothelial growth factor (VEGF) by proximal tubular
epithelial cells (PTEC) in cell culture inserts
Amount of secreted VEGF pg
Site 4 hours 24 hours
Basolateral 148635 298684
Apical 134653 252689
Mean 6 SD of cultures are from 4 different renal tissue donors (4 3 104 cells
per insert, 1 mL medium volume). VEGF production was non-polarized (P .
0.05, paired t-test).
addition of the 32P-labeled oligonucleotide, the reactions
were incubated at 48C overnight. Samples were resolved
by electrophoresis on native 5% polyacrylamide gels
(polyacrylamide/bisacrylamide, 3:0.8) at room tempera-
ture. Gels were dried and analyzed directly by autoradi-
Fig. 1. Vascular endothelial growth factor (VEGF) concentrations inography.
proximal tubule epithelial cell (PTEC) culture media during normoxic
(h, 20% O2) and hypoxic ( , 3% O2) incubation for up to 72 hours.
Statistics Data are mean 6 SD of cultures from 5 separate renal tissue donors;
*P , 0.05 compared with normoxic incubation, paired t-test.Data are presented as the mean and standard devia-
tion (6SD). The paired t-test was used to compare two
groups of matched cultures from the same renal tissue
donor. The Tukey–Kramer test was used for multiple
comparisons. A statistically significant difference was as-
sumed if the two-tailed P value was ,0.05.
RESULTS
Proximal tubular epithelial cells were cultured in poly-
carbonate inserts for study of site-directed VEGF pro-
duction. Measurements of immunoreactive VEGF carried
out after 4- or 24-hour incubation periods revealed that
there was no statistical difference between the amounts
of VEGF secreted to the basolateral versus the apical site
of unstimulated cultures (Table 2). In vivo, this pattern of
Fig. 2. Effects of the addition of phorbol 12-myristate 13-acetatenonpolarized secretion would correspond to the occur-
(PMA; 100 nmol/L), interleukin 1-b (IL-1b; 300 pg/mL), tumor necrosisrence of VEGF in both interstitial and tubular fluid. factor-a (TNF-a; 10 ng/mL), and IL-6 (20 ng/mL) on the 24-hour rates
The following studies were carried out with monolayers of the production of immunoreactive VEGF in PTEC. Data are mean 6
SD of cultures from 5 separate renal tissue donors; *P , 0.001 comparedgrown on the bottom surface of common culture vessels.
to untreated control cultures, Tukey–Kramer test.The rate of the secretion of VEGF was significantly
increased when the cells were maintained under hypoxic
conditions for up to 72 hours (Fig. 1). Measurements of
VEGF mRNA by competitive RT-PCR were not sensi- with IL-1b (300 pg/mL) for four hours (4720 6 2960
tive enough to demonstrate a significant difference when amol/mg total RNA vs. 3920 6 720 amol/mg total RNA
normoxic and hypoxic cultures were compared (2560 6 in control cultures; mean 6 SD of cultures from 4 different
1520 amol/mg total RNA vs. 4960 6 4160 amol/mg total renal tissue donors).
RNA after 24 h of incubation; mean 6 SD of cultures Western blot analysis showed that the amount of
from 6 different renal tissue donors, P . 0.05, paired HIF-1a was increased in nuclear extracts from PTECs on
t-test). treatment with IL-1b or exposure to hypoxia for four
Figure 2 shows that the addition of PMA or IL-1b hours (Fig. 3).
increased the rate of the production of immunoreactive Electrophoretic mobility shift assays showed that hyp-
VEGF by PTECs. No such effect was seen, when the cells oxia led to increased DNA binding of the HIF-1 complex
were treated with TNF-a or IL-6. Measurements of VEGF (Fig. 4). Moreover, incubation with IL-1b was as effective
as hypoxia in activating the HIF complex even undermRNA revealed no significant increase in cultures treated
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from the abluminal side rather than from the luminal
side [29]. Thus, paracrine effects of intrarenally produced
VEGF cannot be excluded.
In normal human kidney, proximal tubules exhibit
only faint, if any, labeling for VEGF mRNA and VEGF
protein, when studied by in situ hybridization and immu-
nohistochemistry [4, 25]. However, in the damaged tu-
bules of kidneys with necrotizing vasculitis and glomeru-
lonephritis, significant staining for VEGF mRNA and
VEGF protein has been demonstrated [4]. Two mecha-
nisms could be responsible for this reaction. First, VEGF
mRNA levels may increase on the induction of hypoxia
[6–8, 30]. Exposure of rodents to inspiratory hypoxia
resulted in increased renal VEGF mRNA levels in one
study [31], but not in another [32]. Although impairedFig. 3. Western blot for hypoxia inducible factor-1a (HIF-1a) in whole
cell extracts from PTECs incubated under normoxic (20%O2) or hyp- renal blood flow may also cause focal hypoxia, it is note-
oxic (3% O2) conditions without or with IL-1b (300 pg/mL) for four worthy that ischemic acute renal failure is not generallyhours. A similar increase of HIF-1a protein on IL-1b treatment was
accompanied by significant peritubular inflammation.seen on Western blots of nuclear extracts.
Second, VEGF gene expression can be induced by immu-
nomodulatory peptides. IL-1 increases VEGF mRNA
levels in rat smooth muscle cells [33], human fibroblasts
normoxic conditions. The effect was stronger when cells [34–36], and tumor cells [37, 38]. The action of TNF-a in
were studied in gas-permeable Petri-PERMt culture VEGF gene expression is more tissue restricted. How-
dishes. To demonstrate the effectiveness of the hypoxic ever, this cytokine is effective in human keratinocytes
incubation, nuclear extracts of mouse hepatoma cells were [35] and some tumor cell lines [37, 39].
tested for HIF-1 DNA binding. Only Hepa1 cells, which To the best of our knowledge, the present study is the
contained both HIF-1 subunits in an active form, showed first to show that human proximal tubular cells produce
hypoxic inducibility, whereas Hepa1C4 cells lacked a func- VEGF in culture. By RT-PCR and ELISA, VEGF mRNA
tional HIF-1b subunit. Specificity of HIF-1 binding was and immunoreactive VEGF protein were demonstrated
confirmed by adding unlabeled TfHBSww-oligonucleo- in PTECs and the culture supernatants, respectively.
tide to the binding reaction. This experiment was not Studies using culture inserts indicated that the cells se-
performed with nuclear extracts from PTECs because creted VEGF in a nonpolarized fashion. The occurrence
of the limited availability of the renal cells. of VEGF on the apical site of the cultures is in line with
the fact that human urine contains VEGF in measurable
amounts. Interestingly, the urinary VEGF/creatinine ra-DISCUSSION
tio is not increased in nephrotic subjects compared with
Initial studies on the localization of the expression of normal subjects [29]. Based on the present in vitro study,
the VEGF gene revealed the lung, kidneys, heart, and we speculate that urinary VEGF may partly originate
adrenal glands as the dominating sites in normal adult from tubules. A functional role cannot be assigned to
guinea pigs [24]. In situ hybridization and immunohisto- urinary VEGF at present.
chemical studies have indicated that the main intrarenal The rate of VEGF secretion in PTEC cultures was
sites of the generation of VEGF are the renal corpuscles increased when the O2 concentration in the incubator
and, here, the podocytes [24, 25]. While renal VEGF was reduced from 20 to 3% or when IL-1b was added
seems to be essential for the capillarization of the meta- to the cells. TNF-a did not stimulate the secretion of
nephros [26, 27], its function in the kidneys of adults is VEGF. In addition, we failed to demonstrate significant
incompletely understood. Experimental studies have not differences in VEGF mRNA levels, when cultures grown
supported the hypothesis that high levels of circulating at 20% O2 were compared with those grown at 3% O2
VEGF might cause an increase of glomerular permeabil- or treated with IL-1b. This failure was probably due to
ity for macromolecules and, therefore, lead to protein- the moderate effects of low O2 concentration and IL-1b,
uria. In isolated perfused rat kidneys, the addition of which increased the amount of secreted VEGF by 20
VEGF to the perfusion does not enhance albumin excre- and 30%, respectively. Whereas the ELISA for immuno-
tion rates [28]. Neither does the intravenous administra- reactive VEGF could still detect this stimulation, the
tion of high doses of VEGF to rats result in the develop- effect was likely below the resolution threshold of the
ment of proteinuria [29]. As pointed out by Webb et al, RT-PCR assay for VEGF mRNA. Several transcription
factors have been implicated in the control of the VEGFhowever, VEGF normally approaches the endothelium
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Fig. 4. Gel shift analysis with nuclear extracts
from PTECs and mouse hepatoma cells
(Hepa1 and Hepa1C4). The cells were incu-
bated under normoxic (20% O2; N) or hypoxic
(3% O2; H) conditions. Normoxic PTECs
were challenged with IL-1b (300 pg/mL) for
four hours. In the competition experiment
(lane H, Hepa1 1 competitor), a 150-fold mo-
lar excess of unlabeled oligonucleotide was
added to the binding reaction. Abbreviations
are: i, inducible DNA-binding activity; c, con-
stitutive DNA-binding activity, n.s., nonspe-
cific DNA-binding activity.
gene, including HIF-1 [9], AP-1 [30, 37], and SP-1 [37]. toma cells, while TNF-a was ineffective in this regard
[12]. This present study extends these findings, as theInterest has been focused on HIF-1 because this tran-
scription factor complex is the key activator of O2-con- addition of IL-1b to cultured primary human proximal
tubular cells resulted in increased HIF-1a immunoreac-trolled genes [40–42]. Originally, HIF-1 was thought to
function solely to mediate responses to O2 and glucose tivity and HIF-1 DNA binding. Thus, the transcription
factor HIF-1 may not only play an important role indeprivation. However, we have recently observed that
IL-1b and TNF-a increase HIF-1 DNA binding in the O2 homeostasis but also in IL-1–mediated inflammatory
processes.human hepatoma cell lines, HepG2 and Hep3B, under
normoxic and hypoxic conditions. HIF-1a protein accu- In conclusion, the demonstration of HIF-1 activation
in human proximal tubular cells supports the conceptmulation was seen only on IL-1b treatment of the hepa-
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DNA-binding of hypoxia-inducible factor-1. Blood 94:1561–1567,that HIF-1 is ubiquitously controlling oxygen-dependent
1999
genes in mammalian cells. Increased HIF-1 DNA bind- 13. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA: Tissue
ing to hypoxia-responsive elements in the VEGF gene culture of human kidney epithelial cells of proximal tubule origin.
Kidney Int 25:383–390, 1984promoter may partly account for the stimulation of
14. Kreft B, Brzoska S, Doehn C, Daha MR, van der Woude FJ,
VEGF production in tubular cells on exposure to hyp- Sack K: 1,25-Dihydroxycholecalciferol enhances the expression of
oxic stress or IL-1b treatment. The secretion of VEGF MHC class II antigens and intercellular adhesion molecule-1 by
human renal tubular epithelial cells. J Urol 155:1448–1453, 1996into the renal interstitium will result in increased micro-
15. Leeker A, Kreft B, Sandmann J, Bates J, Wasenauer G, Mu¨llervascular permeability and monocyte extravasation. The H, Sack K, Kumar S: Tamm-Horsfall protein inhibits binding of S-
extent to which renal proximal tubular cells contribute and P-fimbriated Escherichia coli to human renal tubular epithelial
cells. Exp Nephrol 5:38–46, 1997to this processes remains to be clarified, because VEGF
16. Kru¨ger S, Kliniker M, Kru¨ger S, Brandt E, Kreft B: Interleukin-will also be produced by other resident renal cells and 8 secretion of cortical tubular epithelial cells is directed to the
by leukocytes, when these are challenged by hypoxia basolateral environment and is not enhanced by apical exposure
to Escherichia coli. Infect Immun 68:328–334, 2000and inflammation.
17. Heits F, Katschinski DM, Wiedemann GJ, Weiss C, Jelkmann
W: Serum vascular endothelial growth factor (VEGF), a prognostic
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